BACKGROUND:: Blood in the stomach and esophagus in patients with variceal bleeding
often obscures the endoscopic view and makes endoscopic intervention difficult to perform. …

BACKGROUND AND OBJECTIVES : Hepatitis C virus (HCV) genotype (G) knowledge is
essential for determining type, duration and rate of response to antiviral therapy, possible route …

Background & Aims Differing threshold levels of hepatitis B virus (HBV) DNA and alanine
aminotransferase (ALT) are recommended by international guidelines for commencement of …

Objectives: The aim of this study is to compare the response of hepatitis C virus (HCV)
genotype 4 with other genotypes to anti-viral treatment among Saudi patients in a prospective …

Results: The most frequent clinical presentation was decompensated chronic liver disease
in 19 (47.5%), followed by chronic hepatitis in 15 (37.5%) and fulminant hepatic failure (FHF) …

5-fluorouracil cardiotoxicity is increasingly recognized with variable presentation. We report
a patient who developed cardiogenic shock due to high-dose 5-fluorouracil infusion (1,000 …

Although systemic amyloidosis of amyloid-associated protein (AA) type (secondary or reactive
amyloidosis) frequently involves the liver, it rarely causes clinically apparent liver disease. …

Drug-induced thrombocytopenia is a relatively common clinical condition. However, acute
thrombocytopenia after initiation of piperacillin/tazobactam is rare, with only a few cases …

Optimal doses of Ribavirin (RBV) for hepatitis C virus (HCV) treatment are not known. To
assess the safety and efficacy of PegIFNalfa-2a in combination with an adjusted (ADJ) RBV …

The prevalence of the hepatitis B e antigen (HBeAg)-negative form of chronic hepatitis B (CHB)
has increased over the years and is generally more difficult to treat. Pegylated interferon (…